Bladder, Neurogenic Clinical Trial
Official title:
An Uncontrolled, Open-label, Titration, Long-term Safety (up to 12 Months) and Efficacy Study of Tamsulosin Hydrochloride in Children With Neuropathic Bladder, With a Randomized Pharmacokinetic Sub-study Investigating Low, Medium and High Dose Ranges.
Aims of this study is to characterize the pharmacokinetic/pharmacodynamic profile and evaluate the safety, efficacy and tolerability, of tamsulosin hydrochloride as treatment in children with a neuropathic bladder, over the course of 12 months of active treatment.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03593512 -
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy
|
N/A | |
Not yet recruiting |
NCT03698721 -
Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate
|
||
Active, not recruiting |
NCT00175123 -
Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele
|
Phase 4 | |
Recruiting |
NCT04738539 -
Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
|
||
Completed |
NCT00591240 -
A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
|
N/A | |
Completed |
NCT03908047 -
Functional Changes in the Brain After Tibial Nerve Stimulation: a Pilot Study
|
||
Recruiting |
NCT06337942 -
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
|
N/A | |
Completed |
NCT00796614 -
Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder
|
Phase 2/Phase 3 |